ArticleCancers2024

Usefulness of Nutritional Assessment Indicators in Predicting Treatment Discontinuation Due to Adverse Events from PARP Inhibitors in Ovarian Cancer Patients.

Yoshiaki Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.